Equity

Share Repurchase Authorization Limit

AbbVie Share Repurchase Authorization Limit remained flat by 0.0% to $2.90B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 25.6%, from $3.90B to $2.90B. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ3 2016
Last reportedQ3 2025

How to read this metric

An increase suggests management believes the stock is undervalued or that they have excess cash to return to investors.

Detailed definition

This is the total dollar amount approved by the board of directors for the company to buy back its own common stock from...

Peer comparison

Commonly disclosed by large-cap companies as part of their capital return strategy.

Metric ID: share_repurchase_authorization_limit

Historical Data

14 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25
Value$2.60B$2.60B$1.40B$1.40B$1.40B$4.80B$4.80B$4.80B$3.90B$3.90B$3.90B$2.90B$2.90B$2.90B
QoQ Change+0.0%-46.2%+0.0%+0.0%+242.9%+0.0%+0.0%-18.8%+0.0%+0.0%-25.6%+0.0%+0.0%
YoY Change-46.2%-46.2%+242.9%+242.9%+242.9%-18.8%-18.8%-18.8%-25.6%-25.6%-25.6%
Range$1.40B$4.80B
CAGR+3.4%
Avg YoY Growth+45.7%
Median YoY Growth-18.8%
Current Streak2 quarters growth

Share Repurchase Authorization Limit at Other Companies

Frequently Asked Questions

What is AbbVie's share repurchase authorization limit?
AbbVie (ABBV) reported share repurchase authorization limit of $2.90B in Q3 2025.
How has AbbVie's share repurchase authorization limit changed year-over-year?
AbbVie's share repurchase authorization limit decreased by 25.6% year-over-year, from $3.90B to $2.90B.
What does share repurchase authorization limit mean?
The maximum dollar amount the board has approved for buying back company shares.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.